Zhang Zhihong, Zhou Tingting, Zhang Man, Cheng Shuiqin
National Clinical Research Center of Kidney Diseases, Jinling Hospital, Nanjing University School of Medicine, Nanjing, Jiangsu, China.
Ren Fail. 2025 Dec;47(1):2444389. doi: 10.1080/0886022X.2024.2444389. Epub 2025 Jan 2.
Both serum creatinine and cystatin C serve as dependable markers of renal function and have demonstrated a correlation with clinical outcomes in diverse conditions, particularly through the ratio of creatinine to cystatin C (Cr/CysC). Anuric patients undergoing peritoneal dialysis (PD) depend entirely on the clearance of peritoneal solutes. This research posits that the Cr/CysC ratio may predict all-cause mortality and technique failure in anuric PD patients.
A cohort of 224 anuric PD patients was recruited from January 1, 2014, to December 31, 2019, with follow-up extending until December 31, 2023. The Cr/CysC ratio was computed by dividing the serum creatinine concentration by the cystatin C concentration obtained on the same day. We evaluated the relationship between the Cr/CysC ratio and patient survival, as well as technique failure, utilizing Cox regression and competing risk analyses.
The average age of the participants was 50.46 ± 12.63 years, with 99 individuals (44.2%) being male. Among all subjects, the Cr/CysC ratio was found to be 1.85 ± 0.56. After controlling for potential confounders, Cox proportional hazards models revealed that the Cr/CysC ratio was significantly linked to the risk of all-cause mortality and technique failure (HR = 0.330, 95% CI 0.124-0.881, = 0.027; HR = 0.440, 95% CI 0.267-0.726, = 0.002). Importantly, the significant associations observed in the Cox regression analysis persisted even after accounting for competing risks.
The Cr/CysC ratio at baseline was recognized as an independent predictor of all-cause mortality and technique failure in anuric PD patients.
血清肌酐和胱抑素C均为可靠的肾功能标志物,并且已证实在多种情况下与临床结局相关,尤其是通过肌酐与胱抑素C的比值(Cr/CysC)。接受腹膜透析(PD)的无尿患者完全依赖腹膜溶质清除。本研究假定Cr/CysC比值可预测无尿PD患者的全因死亡率和技术失败。
从2014年1月1日至2019年12月31日招募了224名无尿PD患者队列,随访至2023年12月31日。Cr/CysC比值通过将血清肌酐浓度除以同一天获得的胱抑素C浓度来计算。我们利用Cox回归和竞争风险分析评估了Cr/CysC比值与患者生存率以及技术失败之间的关系。
参与者的平均年龄为50.46±12.63岁,其中99人(44.2%)为男性。在所有受试者中,Cr/CysC比值为1.85±0.56。在控制潜在混杂因素后,Cox比例风险模型显示Cr/CysC比值与全因死亡率和技术失败风险显著相关(HR = 0.330,95%CI 0.124 - 0.881,P = 0.027;HR = 0.440,95%CI 0.267 - 0.726,P = 0.002)。重要的是,即使在考虑竞争风险后,Cox回归分析中观察到的显著关联仍然存在。
基线时的Cr/CysC比值被认为是无尿PD患者全因死亡率和技术失败的独立预测因素。